SEC Form 4 · accession 0001209191-16-155688
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoff Race
Officer — EVP, CFO & Chief Business Off.
Period of report
Dec 14, 2016
Accepted (ET)
Dec 16, 2016 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Dec 14, 2016 | A | 50,000 | A | — | — | Common Stock | 50,000 | 50,000 | D |
| Employee Stock Option (Right to Buy)F3,F4 | $13.45 | Dec 14, 2016 | A | 100,000 | A | — | Dec 13, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock
- F2Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.
- F3The exercise price is the closing price of the Issuer's common stock on December 14, 2016.
- F4This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter.